XML 21 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 230 $ 206
Marketable securities 700 803
Receivable from collaboration partners ($32 and $39 from a related party) 34 39
Prepaid expenses and other current assets 22 19
Total current assets 986 1,067
Long-term marketable securities 80 129
Property and equipment, net 45 35
Other noncurrent assets ($5 and $2 from a related party) 109 114
Total assets 1,220 1,345
Current liabilities:    
Accounts payable 12 20
Deferred revenue ($103 and $97 to a related party) 103 97
Other current liabilities 65 76
Total current liabilities 180 193
Deferred revenue, noncurrent ($330 and $355 to a related party) 330 355
Other noncurrent liabilities 144 140
Commitments
Stockholders’ equity:    
Preferred stock, $0.0001 par value per share; 10.0 shares authorized; no shares issued and outstanding   0
Common stock and additional paid-in capital: $0.0001 par value per share; 400.0 shares authorized; 74.5 shares in 2023 and 72.9 shares in 2022 issued and outstanding 1,267 1,206
Accumulated deficit (697) (542)
Accumulated other comprehensive loss (4) (7)
Total stockholders’ equity 566 657
Total liabilities and stockholders’ equity $ 1,220 $ 1,345